GlassScriptPhysician profile
Angie Chan
NPI 1104571801
$1,625.85
in general payments reported to CMS, 2019-2025
15 companies · $608 in 2025
The $608 reported for 2025 was more than what 82% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $593 · 2024: $424 · 2025: $608.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,527 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,526.85 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $519.28 | 2023-2025 | |
| Regeneron Healthcare Solutions, INC. | $221.90 | 2024-2025 | Dupixent, Libtayo |
| Incyte Corporation | $156.40 | 2023-2025 | Opzelura |
| Janssen Biotech, INC. | $146.56 | 2024-2025 | Tremfya |
| Amgen INC. | $110.80 | 2023-2025 | Otezla, Otezla |
| Sun Pharmaceutical Industries INC. | $106.46 | 2023-2025 | Winlevi, Absorica Ld |
| Mayne Pharma Commercial LLC | $80.63 | 2023 | |
| Novartis Pharmaceuticals Corporation | $63.53 | 2024-2025 | |
| Genzyme Corporation | $53.57 | 2023-2025 | |
| Botanix Sb INC | $41.77 | 2025 | Sofdra |
| Leo Pharma INC. | $29.86 | 2023 | Adbry |
| Journey Medical Corporation | $28.88 | 2023 | |
| Galderma Laboratories, L.P. | $23.72 | 2025 | Aklief |
| Verrica Pharmaceuticals INC. | $22.24 | 2024 | Ycanth |
| Lilly USA, LLC | $20.25 | 2024 | Ebglyss |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angie Chan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.